A 73-year-old man with symptomatic benign prostatic hyperplasia.
Barry
M J
MJ
Health Services Research Program, Massachusetts General Hospital, Boston, USA.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D017115:Catheter Ablation; D003657:Decision Making; D017292:Doxazosin / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D053685:Laser Therapy; D008297:Male; D011468:Prostatectomy; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery; D011471:Prostatic Neoplasms / Q000175:diagnosis; D014223:Triamterene / Q000627:therapeutic use; D014555:Urination Disorders / Q000188:drug therapy / Q000209:etiology
D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D004338:Drug Combinations; D004791:Enzyme Inhibitors; D006852:Hydrochlorothiazide; C020743:hydrochlorothiazide-triamterene; D018120:Finasteride; D017292:Doxazosin; D014223:Triamterene